Novel Labs Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NOVEL LABS INC, and what generic and branded alternatives to NOVEL LABS INC drugs are available?
NOVEL LABS INC has fifty-six approved drugs.
There are three tentative approvals on NOVEL LABS INC drugs.
Drugs and US Patents for Novel Labs Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novel Labs Inc | CEVIMELINE HYDROCHLORIDE | cevimeline hydrochloride | CAPSULE;ORAL | 204746-001 | Dec 30, 2016 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Novel Labs Inc | FLUCYTOSINE | flucytosine | CAPSULE;ORAL | 204652-002 | Jul 7, 2017 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Novel Labs Inc | POTASSIUM CHLORIDE | potassium chloride | TABLET, EXTENDED RELEASE;ORAL | 206347-001 | Jan 21, 2016 | AB1 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Novel Labs Inc | PEG 3350 AND ELECTROLYTES | polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous | FOR SOLUTION;ORAL | 090186-001 | Jun 1, 2009 | AA | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.